The significant differences observed between the histological subtypes of gastric cancer, specifically diffuse and intestinal types, in relation to FOLR1 and FOLR2 expressions, align with the growing body of evidence that suggests molecular heterogeneity within gastric cancer subtypes [18]. This evidence concerns the gene FOLR2 and gastric cancer.